Lunaphore Technologies, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF
The post Lunaphore receives CHF23m series c financing, led by PHC holdings appeared first on NS Medical Devices.
Original Article: Lunaphore receives CHF23m series c financing, led by PHC holdings